Status:
COMPLETED
Human Ovarian Autotransplantation
Lead Sponsor:
Samuel Kim, MD
Conditions:
Ovarian Autotransplantation Using Cryopreserved Ovarian Tissue in Women Treated for Cancer
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Chemotherapy can cause permanent damage to a woman's ovaries. Women who are cancer survivors may find that they are not able to produce female hormones, and they may not be able to have a child. Scien...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Adult women (age between 18 and 40) who stored the ovary before cancer therapy.
- Adult women who completed cancer therapy and are in remission.
- Adult women who desire to conceive and are ready to have a baby.
- Exclusion criteria:
- Age under 18 or over 40 years old
- Women with a disease at high risk for ovarian metastasis (such as leukemia)
- Women with contraindication for surgery
- Women with contraindication for pregnancy
- Psychological instability to sustain pregnancy (diagnosed by a psychiatrist)
- Women who are HIV Positive
Exclusion
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT01403675
Start Date
May 1 2009
End Date
March 1 2014
Last Update
December 4 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Kansas Medical Center
Kansas City, Kansas, United States, 66160